Search Results

Cover Focus

Standalone MIGS

Weighing the benefits and risks of surgical approaches.

Nathan M. Radcliffe, MD

Health Care

Reflections on the Reimbursement Landscape

Insights into recent events and points of advice for the future.

Iqbal Ike K. Ahmed, MD, FRCSC; Arsham Sheybani, MD; and Nathan M. Radcliffe, MD

Seen & Heard

Shifting Paradigms in Glaucoma and GA

New treatments and mindsets are changing care.

Nathan M. Radcliffe, MD; John Kitchens, MD; and Deborah Ristvedt, DO

Case Files

Progressive Glaucoma and a Desire for Perfect Vision

Can the patient’s expectations be met?

Jacob Brubaker, MD; Joseph F. Panarelli, MD; Nathan M. Radcliffe, MD; Manjool Shah, MD; and Sarah H. Van Tassel, MD

The Pipeline

Direct Selective Laser Trabeculoplasty

Expanding access to and delivery of SLT poses a great challenge.

Nathan M. Radcliffe, MD

The Buzz on Eyetube

Cover Focus

Glaucoma Visionaries: Nathan M. Radcliffe, MD

Nathan M. Radcliffe, MD

Seen & Heard

Case Files

Intolerant of All Glaucoma Medications

What is the next step when glaucoma is progressing and IOP is elevated after laser trabeculoplasty?

Steven R. Sarkisian Jr, MD; Sahar Bedrood, MD, PhD; Nathan M. Radcliffe, MD; and Manjool Shah, MD

Cover Focus

Back to the Cornea: Corneal Hysteresis in Action

Ophthalmologists share cases in which this measurement influenced their treatment plans.

Davinder S. Grover, MD, MPH; Nathan M. Radcliffe, MD; Nicholas Tan, BA; and John P. Berdahl, MD

Digital Supplement

Ushering in a New Treatment Paradigm for Glaucoma: Updates on Novel Therapeutics and Disease-Modifying Treatments

Nathan M. Radcliffe, MD; Earl Randy Craven, MD; Preeya K. Gupta, MD; and Robert N. Weinreb, MD

Bench To Bedside

Tonometry Debate

Industry weighs in on the IOP measurement discussion.

David A. Taylor and Dan Eisenberg, MD

Bench To Bedside

Tonometry Debate

Industry weighs in on the IOP measurement discussion.

David A. Taylor and Dan Eisenberg, MD

Bench To Bedside

What Is the Real IOP?

How laboratory glaucoma studies may help us better understand this clinical dilemma.

Nathan Radcliffe, MD

Structure and Function in Clinical Practice

Combining structure and function into a single, continuous variable would be advantageous.

Nathan Radcliffe, MD

Glaucoma Drugs in the Pipeline

Physicians share which coming therapies they are most eager to use in their practices.

Malik Y. Kahook, MD; Paul L. Kaufman, MD; Robert J. Noecker, MD, MBA; and Nathan M. Radcliffe, MD

Glaucoma Drugs in the Pipeline

Physicians share which coming therapies they are most eager to use in their practices.

Malik Y. Kahook, MD; Paul L. Kaufman, MD; Robert J. Noecker, MD, MBA; and Nathan M. Radcliffe, MD

Industry News and Innovations

Optical Coherence Tomography in Glaucoma

An essential imaging modality for diagnosis, monitoring, and management of the disease.

Nathan M. Radcliffe, MD, and Syed Amal Hussnain, MD